Consortium lead by Prophylix Pharma AS receives up to €6 M in…

The EU grant is for development of a prophylactic treatment to prevent severe bleeding and death in newborns caused by Fetal/Neonatal Alloimmune Trombocytopenia

(PRWeb May 08, 2012)

Read the full story at

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: